Bioavailability and Dose-Proportionality of Meloxicam 7.5 mg and 15 mg Tablets in Healthy Volunteers

Phase 1, randomised, open-label trial of meloxicam in osteoarthritis (OA) and rheumatoid arthritis (RA) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Maximum measured concentration of the analyte in plasma and Area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity. Started Jun 1999; status: completed.